Moreover, exploring the targeting of Rab27 in combination with other proteins involved in sEV secretion, such as TSG101, could additionally improve the therapeutic outcome and become a novel strategy for preventing melanoma progression and metastasis. This evidence concerns the gene TSG101 and melanoma.